Properties of melt extruded enteric matrix pellets
- PMID: 19782133
- DOI: 10.1016/j.ejpb.2009.09.008
Properties of melt extruded enteric matrix pellets
Abstract
The objective of this study was to investigate the properties of enteric matrix pellets that were prepared by hot-melt extrusion in a one-step, continuous process. Five polymers (Eudragit) L100-55, L100 and S100, Aqoat grades LF and HF) were investigated as possible matrix formers, and pellets prepared with Eudragit S100 demonstrated superior gastric protection and acceptable processibility. Extruded pellets containing Eudragit S100 and up to 40% theophylline released less than 10% drug over 2h in acid, however, the processibility and yields were compromised by the high amounts of the non-melting drug material in the formulation. Efficient plasticization of Eudragit S100 was necessary to reduce the polymer's glass transition temperature and melt viscosity. Five compounds including triethyl citrate, methylparaben, polyethylene glycol 8000, citric acid monohydrate and acetyltributyl citrate were investigated in terms of plasticization efficiency and preservation of the delayed drug release properties. The aqueous solubility of the plasticizer and its plasticization efficiency impacted the drug release rate from the matrix pellets. The use of water-soluble plasticizers resulted in a loss of gastric protection, whereas low drug release rates in acid were found for pellets containing insoluble plasticizers or no plasticizer, independent of the extent of Eudragit S100 plasticization. The release rate of theophylline in buffer pH 7.4 was faster for pellets that were prepared with efficient plasticizers. The microstructure and solid-state properties of plasticized pellets were further investigated by scanning electron microscopy and powder X-ray diffraction. Pellets prepared with efficient plasticizers (TEC, methylparaben, PEG 8000) exhibited matrices of low porosity, and the drug was homogeneously dispersed in its original polymorphic form. Pellets containing ATBC or citric acid monohydrate had to be extruded at elevated temperature and showed physical instabilities in the form of recrystallization at room temperature. Enteric matrix pellets with a diameter below 1mm and containing 30% theophylline could be successfully prepared by hot-melt extrusion when Eudragit S100 plasticized with either TEC or methylparaben was employed as the matrix material.
Copyright (c) 2009 Elsevier B.V. All rights reserved.
Similar articles
-
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.AAPS PharmSciTech. 2016 Feb;17(1):43-55. doi: 10.1208/s12249-015-0393-y. Epub 2015 Aug 26. AAPS PharmSciTech. 2016. PMID: 26307759 Free PMC article. Review.
-
Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.J Microencapsul. 2010;27(6):521-32. doi: 10.3109/02652048.2010.484105. J Microencapsul. 2010. PMID: 20575612
-
Crystal growth formation in melt extrudates.Int J Pharm. 2007 Aug 16;341(1-2):162-72. doi: 10.1016/j.ijpharm.2007.04.008. Epub 2007 Apr 19. Int J Pharm. 2007. PMID: 17524578
-
Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.Int J Pharm. 2006 Oct 12;323(1-2):11-7. doi: 10.1016/j.ijpharm.2006.05.043. Epub 2006 May 27. Int J Pharm. 2006. PMID: 16815652
-
Preparation of the traditional Chinese medicine compound recipe heart-protecting musk pH-dependent gradient-release pellets.Drug Dev Ind Pharm. 2002 Nov;28(10):1261-73. doi: 10.1081/ddc-120015360. Drug Dev Ind Pharm. 2002. PMID: 12476872 Review.
Cited by
-
Taste Masked Orally Disintegrating Pellets of Antihistaminic and Mucolytic Drug: Formulation, Characterization, and In Vivo Studies in Human.Int Sch Res Notices. 2014 Oct 28;2014:504536. doi: 10.1155/2014/504536. eCollection 2014. Int Sch Res Notices. 2014. PMID: 27379290 Free PMC article.
-
Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.AAPS PharmSciTech. 2016 Feb;17(1):43-55. doi: 10.1208/s12249-015-0393-y. Epub 2015 Aug 26. AAPS PharmSciTech. 2016. PMID: 26307759 Free PMC article. Review.
-
Continuous Manufacturing of Ketoprofen Delayed Release Pellets Using Melt Extrusion Technology: Application of QbD Design Space, Inline Near Infrared, and Inline Pellet Size Analysis.J Pharm Sci. 2020 Dec;109(12):3598-3607. doi: 10.1016/j.xphs.2020.09.007. Epub 2020 Sep 8. J Pharm Sci. 2020. PMID: 32916139 Free PMC article.
-
Optimization of pellets containing solid dispersion prepared by extrusion/spheronization using central composite design and desirability function.J Young Pharm. 2012 Jul;4(3):146-56. doi: 10.4103/0975-1483.100020. J Young Pharm. 2012. PMID: 23112533 Free PMC article.
-
Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.AAPS PharmSciTech. 2015 Aug;16(4):878-88. doi: 10.1208/s12249-014-0252-2. Epub 2015 Jan 16. AAPS PharmSciTech. 2015. PMID: 25591951 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous